论文信息 - 168P Sacituzumab govitecan (SG) efficacy in patients with metastatic triple-negative breast cancer (mTNBC) by HER2 immunohistochemistry (IHC) status: Findings from the phase III ASCENT study - 字舞流文

168P Sacituzumab govitecan (SG) efficacy in patients with metastatic triple-negative breast cancer (mTNBC) by HER2 immunohistochemistry (IHC) status: Findings from the phase III ASCENT study

A. Bardia | J. O’Shaughnessy | V. Diéras | K. Punie | S. Hurvitz | S. Hofsess | J. Cortés | K. Kalinsky | S. Phan | L. Carey | H. Rugo | R. Delaney | P. Hodgkins | Y. Pan | O.K. Yoon